Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Friday's trading session produced marked intraday volatility across market-cap ranges, with mega-cap Apple among notable decliners and a mix of large-, mid- and small-cap names swinging sharply higher or lower. Several companies reported earnings or guidance that coincided with steep share moves, while analyst actions and other company-specific cat…
Everus Construction Group said it has signed a definitive agreement to acquire Epsilon Industries for $295 million in cash, an acquisition to be financed with existing cash and borrowings. The transaction, which prompted a 3.9% rise in Everus shares, is slated to close in the third quarter of 2026 pending regulatory approvals and customary closing …
A Government Accountability Office report finds the U.S. Air Force's $21 billion program to modernize B-52 bombers - managed by Boeing - is encountering cost increases, schedule slippages and performance shortfalls across the majority of its upgrade efforts. The F130-200 engine program from Rolls-Royce has seen the largest cost rise and notable sch…
Perella Weinberg Partners shares jumped 19.3% in morning trading after the advisory firm posted adjusted EPS of $0.20, about double consensus expectations of roughly $0.10, and reported $157 million in revenue. The beat was amplified by depressed sentiment heading into the release, including a fresh 52-week low and steep cuts to EPS forecasts. The …
Vertiv's Q2 revenue miss has rattled the stock, but the company's core exposure to AI data center power and cooling plus strong cash generation make this a compelling trade. We upgrade to long and lay out a clear entry at $240.20, a $360 target and a $210 stop for a long-term (180 trading days) tactical position.
MongoDB's stock has pulled back from its 52-week highs, but the business metrics that matter - Atlas growth, positive free cash flow of $591M and improving technicals - point to a mid-term buying opportunity. This trade idea outlines an entry at $328.00, a $400 target and a $300 stop, with a primary horizon of 45 trading days and clear catalysts an…
Banco Santander Brasil's ADR leapt 12.5% in morning trading to $5.68, reversing much of a sharp selloff that followed disappointing Q2 2026 results and a downgrade from JPMorgan. The bank reported recurring net income of BRL 3 billion and a 12.5% return on average equity, while acknowledging higher credit costs and a deliberate move to a more conse…
BioAge Labs stock plunged roughly 60% following Novo Nordisk’s announcement that its Phase 3 ZEUS study of ziltivekimab did not reduce the risk of major adverse cardiovascular events versus placebo in more than 6,300 patients. The outcome, which produced a hazard ratio of 0.99, hit investor confidence in inflammation-targeting cardiovascular therap…
Citi told clients that capital flows into South Korea's Kospi show clear buy-on-dip behavior, citing a record single-day foreign net purchase, a sharp moderation in monthly foreign net selling, accelerated passive inflows, tighter retail rules for leveraged ETFs, and renewed pension buying. The bank maintained a Kospi target of 10,000 and flagged p…
Karyopharm Therapeutics shares plunged in morning trading after its Phase 3 XPORT-EC-042 trial of selinexor in TP53 wild-type advanced or recurrent endometrial cancer failed to meet the primary endpoint for progression-free survival. The miss led management to scale back investment in the endometrial program and analysts to sharply lower ratings an…
DexCom shares jumped sharply after the company reported second-quarter 2026 results that exceeded consensus across key metrics. Strong revenue and adjusted EPS, improved gross margins tied to manufacturing gains and product rollout, updated full-year guidance, sizable free cash flow and a large share-repurchase program combined with analyst target …
Moleculin Biotech, a Nasdaq-listed clinical-stage pharmaceutical company, announced the pricing of a $9.3 million public offering consisting of common stock and warrants. The proceeds will fund further clinical development of its lead drug candidate Annamycin, targeting relapsed or refractory acute myeloid leukemia and soft tissue sarcoma lung meta…
Greenland Mines reports increased international interest in Greenland's mineral potential following public remarks by U.S. political figures about the island's strategic importance. The Nasdaq-listed miner is advancing the Skaergaard precious metals project and, pending a transaction close, the Sarfartoq neodymium-praseodymium rare earths project, …
Ares Management Corp Chief Executive Michael Arougheti said the firm could logically broaden its private equity footprint, but only if any acquisition satisfied a range of strategic, cultural and financial criteria. His remarks followed media reports that Ares had been in acquisition discussions with a smaller company in the private markets.
W.P. Carey offers a roughly 5% yield, built-in rent escalators across a 1,700+ net-lease portfolio, and free cash flow that still covers the dividend. The stock trades near mid-range of its 52-week band with reasonable valuation (P/B ~2, P/E ~25.6) and an enterprise value of about $25.6B. We recommend a tactical long: entry $73.56, target $78.00, s…
CN announced its 2026-2027 Grain Plan, forecasting shipment of 30 to 33 million metric tonnes of grain and processed grain products. The company highlights its robust capacity, collaborative efforts across the supply chain, transparency through regular performance reporting, and adaptability to market conditions. This plan supports Canadian agricul…
Bond yields across the euro zone and the United States are on track for their largest monthly rise since March, driven by worries that the conflict in the Middle East could boost inflation and prompt tighter monetary policy. Long-term yields climbed more than short-term rates in July as investors weighed the prospect of sustained hostilities, highe…
Corteva shares slid about 8.6% in morning trading after the company reported second-quarter revenue that fell short of analyst expectations. While adjusted EPS topped estimates and management nudged up full-year earnings guidance, the revenue shortfall in Corteva's most seasonal quarter, a sizable discretionary pension contribution due imminently, …
T. Rowe Price shares dropped sharply after the Baltimore-based asset manager reported second-quarter 2026 results. Despite posting adjusted diluted EPS of $2.57 and revenue of $1.91 billion, both beating expectations, investors focused on $6.5 billion in net client outflows. The company’s AUM rose to $1.89 trillion year-over-year, but persistent re…
Shares of GE Vernova climbed 4.8% in morning trading to $1,029.07 as investors bought into a rebound from a steep post-earnings decline. Analysts have widely characterized the initial selloff as an overreaction to a quarter that featured record orders, raised guidance and strong contract wins, prompting several price-target increases that now sit w…
Mizuho's TMT team pushed back on investor fears that Chinese memory maker CXMT will overwhelm the DRAM market following its IPO. The bank estimates CXMT's DRAM bit growth will trail the industry in 2027, capping its global share at about 8% and producing a 2026-2028 CAGR roughly in line with peers. Analysts point to equipment service suspensions, a…
Euronext rose sharply after posting Q2 2026 results that exceeded analyst expectations across major metrics. Underlying revenue and income hit €544.4 million, adjusted EBITDA climbed to €360 million with a 66.1% margin, and adjusted EPS of €2.42 topped forecasts. The beat, broad segment growth and a constructive market environment drove a 5.7% intr…
Telix (TLX) is executing across commercial rollouts and multiple late-stage programs while stitching together a platform approach to radiopharmaceuticals. With Q2 revenue of $247M, Precision Medicine sales of $202M, and FY2026 guidance to exceed $1B, the business is shifting from single-product commercial risk to a scalable radiopharma operating sy…
Roblox faced downgrades from BMO Capital Markets and Deutsche Bank following a second-quarter report and outlook that fell short of expectations. Analysts pointed to a platform transition that has reduced near-term monetization, booking shortfalls for the quarter, and guidance that signals the first year-over-year revenue decline in the company's h…
ExxonMobil and Chevron delivered very strong second-quarter profits as disruption in the Strait of Hormuz lifted crude prices and refining margins. Exxon reported $14.5 billion in net income and Chevron posted $12.1 billion, while refining spreads and product shortages amplified earnings despite late-quarter oil price declines.
